• レポートコード:GIR201107561 • 出版社/出版日:GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、102ページ • 納品方法:Eメール • 産業分類:医薬品・医療 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本書では、プロスタグランジンE2受容体EP4サブタイプの世界市場を調査対象にし、プロスタグランジンE2受容体EP4サブタイプの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(E-7046、ER-886046、グラピパント、KAG-308、ONO-4232、その他)、用途別分析(乳がん、アレルギー、慢性痛、急性痛、肺がん、その他)、市場予測(2021年~2025年)、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報:Eisai Co Ltd、Ono Pharmaceutical Co Ltd、Eli Lilly and Co、Kaken Pharmaceutical Co Ltd、Rottapharm Biotech Srl、RaQualia Pharma Inc ・メーカー別販売量、売上、市場シェア ・プロスタグランジンE2受容体EP4サブタイプの地域別市場分析 ・プロスタグランジンE2受容体EP4サブタイプの北米市場規模2015-2020:アメリカ、カナダ、メキシコ ・プロスタグランジンE2受容体EP4サブタイプのヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど ・プロスタグランジンE2受容体EP4サブタイプのアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど ・プロスタグランジンE2受容体EP4サブタイプの南米市場規模2015-2020:ブラジル、アルゼンチンなど ・プロスタグランジンE2受容体EP4サブタイプの中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど ・プロスタグランジンE2受容体EP4サブタイプの種類別市場規模2015-2020:E-7046、ER-886046、グラピパント、KAG-308、ONO-4232、その他 ・プロスタグランジンE2受容体EP4サブタイプの用途別市場規模2015-2020:乳がん、アレルギー、慢性痛、急性痛、肺がん、その他 ・プロスタグランジンE2受容体EP4サブタイプの世界市場予測2021-2025:地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Prostaglandin E2 Receptor EP4 Subtype market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Prostaglandin E2 Receptor EP4 Subtype market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Prostaglandin E2 Receptor EP4 Subtype market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Prostaglandin E2 Receptor EP4 Subtype market has been segmented into
E-7046
ER-886046
grapiprant
KAG-308
ONO-4232
Others
By Application, Prostaglandin E2 Receptor EP4 Subtype has been segmented into:
Breast Cancer
Allergies
Chronic Pain
Acute Pain
Lung Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Prostaglandin E2 Receptor EP4 Subtype market presented in the report. This section sheds light on the sales growth of different regional and country-level Prostaglandin E2 Receptor EP4 Subtype markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostaglandin E2 Receptor EP4 Subtype market.
The report offers in-depth assessment of the growth and other aspects of the Prostaglandin E2 Receptor EP4 Subtype market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Prostaglandin E2 Receptor EP4 Subtype Market Share Analysis
Prostaglandin E2 Receptor EP4 Subtype competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prostaglandin E2 Receptor EP4 Subtype sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Prostaglandin E2 Receptor EP4 Subtype sales, revenue and market share for each player covered in this report.
The major players covered in Prostaglandin E2 Receptor EP4 Subtype are:
Eisai Co Ltd
Ono Pharmaceutical Co Ltd
Eli Lilly and Co
Kaken Pharmaceutical Co Ltd
Rottapharm Biotech Srl
RaQualia Pharma Inc
Among other players domestic and global, Prostaglandin E2 Receptor EP4 Subtype market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostaglandin E2 Receptor EP4 Subtype product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Prostaglandin E2 Receptor EP4 Subtype, with price, sales, revenue and global market share of Prostaglandin E2 Receptor EP4 Subtype in 2018 and 2019.
Chapter 3, the Prostaglandin E2 Receptor EP4 Subtype competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostaglandin E2 Receptor EP4 Subtype breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Prostaglandin E2 Receptor EP4 Subtype market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Prostaglandin E2 Receptor EP4 Subtype sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Prostaglandin E2 Receptor EP4 Subtype Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 E-7046
1.2.3 ER-886046
1.2.4 grapiprant
1.2.5 KAG-308
1.2.6 ONO-4232
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Cancer
1.3.3 Allergies
1.3.4 Chronic Pain
1.3.5 Acute Pain
1.3.6 Lung Cancer
1.3.7 Others
1.4 Overview of Global Prostaglandin E2 Receptor EP4 Subtype Market
1.4.1 Global Prostaglandin E2 Receptor EP4 Subtype Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eisai Co Ltd
2.1.1 Eisai Co Ltd Details
2.1.2 Eisai Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eisai Co Ltd SWOT Analysis
2.1.4 Eisai Co Ltd Product and Services
2.1.5 Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ono Pharmaceutical Co Ltd
2.2.1 Ono Pharmaceutical Co Ltd Details
2.2.2 Ono Pharmaceutical Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ono Pharmaceutical Co Ltd SWOT Analysis
2.2.4 Ono Pharmaceutical Co Ltd Product and Services
2.2.5 Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly and Co
2.3.1 Eli Lilly and Co Details
2.3.2 Eli Lilly and Co Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lilly and Co SWOT Analysis
2.3.4 Eli Lilly and Co Product and Services
2.3.5 Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Kaken Pharmaceutical Co Ltd
2.4.1 Kaken Pharmaceutical Co Ltd Details
2.4.2 Kaken Pharmaceutical Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Kaken Pharmaceutical Co Ltd SWOT Analysis
2.4.4 Kaken Pharmaceutical Co Ltd Product and Services
2.4.5 Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Rottapharm Biotech Srl
2.5.1 Rottapharm Biotech Srl Details
2.5.2 Rottapharm Biotech Srl Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Rottapharm Biotech Srl SWOT Analysis
2.5.4 Rottapharm Biotech Srl Product and Services
2.5.5 Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 RaQualia Pharma Inc
2.6.1 RaQualia Pharma Inc Details
2.6.2 RaQualia Pharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 RaQualia Pharma Inc SWOT Analysis
2.6.4 RaQualia Pharma Inc Product and Services
2.6.5 RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Prostaglandin E2 Receptor EP4 Subtype Manufacturer Market Share in 2019
3.3.2 Top 6 Prostaglandin E2 Receptor EP4 Subtype Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales, Revenue and Market Share by Regions
4.1.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales and Market Share by Regions (2015-2020)
4.1.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue and Market Share by Regions (2015-2020)
4.2 North America Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
4.3 Europe Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
4.5 South America Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Prostaglandin E2 Receptor EP4 Subtype Sales, Revenue and Market Share by Country
5.1.1 North America Prostaglandin E2 Receptor EP4 Subtype Sales and Market Share by Country (2015-2020)
5.1.2 North America Prostaglandin E2 Receptor EP4 Subtype Revenue and Market Share by Country (2015-2020)
5.2 United States Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
5.3 Canada Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
5.4 Mexico Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Prostaglandin E2 Receptor EP4 Subtype Sales, Revenue and Market Share by Country
6.1.1 Europe Prostaglandin E2 Receptor EP4 Subtype Sales and Market Share by Country (2015-2020)
6.1.2 Europe Prostaglandin E2 Receptor EP4 Subtype Revenue and Market Share by Country (2015-2020)
6.2 Germany Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
6.3 UK Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
6.4 France Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
6.5 Russia Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
6.6 Italy Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue and Market Share by Regions (2015-2020)
7.2 China Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
7.3 Japan Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
7.4 Korea Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
7.5 India Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
7.7 Australia Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Prostaglandin E2 Receptor EP4 Subtype Sales, Revenue and Market Share by Country
8.1.1 South America Prostaglandin E2 Receptor EP4 Subtype Sales and Market Share by Country (2015-2020)
8.1.2 South America Prostaglandin E2 Receptor EP4 Subtype Revenue and Market Share by Country (2015-2020)
8.2 Brazil Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
8.3 Argentina Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
9.3 Turkey Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
9.4 Egypt Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
9.5 South Africa Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales and Market Share by Type (2015-2020)
10.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue and Market Share by Type (2015-2020)
10.3 Global Prostaglandin E2 Receptor EP4 Subtype Price by Type (2015-2020)
11 Global Prostaglandin E2 Receptor EP4 Subtype Market Segment by Application
11.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Application (2015-2020)
11.2 Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Application (2015-2020)
11.3 Global Prostaglandin E2 Receptor EP4 Subtype Price by Application (2015-2020)
12 Market Forecast
12.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales, Revenue and Growth Rate (2021-2025)
12.2 Prostaglandin E2 Receptor EP4 Subtype Market Forecast by Regions (2021-2025)
12.2.1 North America Prostaglandin E2 Receptor EP4 Subtype Market Forecast (2021-2025)
12.2.2 Europe Prostaglandin E2 Receptor EP4 Subtype Market Forecast (2021-2025)
12.2.3 Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Market Forecast (2021-2025)
12.2.4 South America Prostaglandin E2 Receptor EP4 Subtype Market Forecast (2021-2025)
12.2.5 Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Market Forecast (2021-2025)
12.3 Prostaglandin E2 Receptor EP4 Subtype Market Forecast by Type (2021-2025)
12.3.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales Forecast by Type (2021-2025)
12.3.2 Global Prostaglandin E2 Receptor EP4 Subtype Market Share Forecast by Type (2021-2025)
12.4 Prostaglandin E2 Receptor EP4 Subtype Market Forecast by Application (2021-2025)
12.4.1 Global Prostaglandin E2 Receptor EP4 Subtype Sales Forecast by Application (2021-2025)
12.4.2 Global Prostaglandin E2 Receptor EP4 Subtype Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Prostaglandin E2 Receptor EP4 Subtype Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Prostaglandin E2 Receptor EP4 Subtype by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Prostaglandin E2 Receptor EP4 Subtype Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Eisai Co Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Major Business
Table 9. Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Total Revenue (USD Million) (2018-2019)
Table 10. Eisai Co Ltd SWOT Analysis
Table 11. Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product and Services
Table 12. Eisai Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Ono Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Major Business
Table 15. Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Total Revenue (USD Million) (2018-2019)
Table 16. Ono Pharmaceutical Co Ltd SWOT Analysis
Table 17. Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product and Services
Table 18. Ono Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Eli Lilly and Co Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Major Business
Table 21. Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Total Revenue (USD Million) (2018-2019)
Table 22. Eli Lilly and Co SWOT Analysis
Table 23. Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Product and Services
Table 24. Eli Lilly and Co Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Kaken Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 26. Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Major Business
Table 27. Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Total Revenue (USD Million) (2018-2019)
Table 28. Kaken Pharmaceutical Co Ltd SWOT Analysis
Table 29. Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Product and Services
Table 30. Kaken Pharmaceutical Co Ltd Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Rottapharm Biotech Srl Basic Information, Manufacturing Base and Competitors
Table 32. Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Major Business
Table 33. Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Total Revenue (USD Million) (2018-2019)
Table 34. Rottapharm Biotech Srl SWOT Analysis
Table 35. Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Product and Services
Table 36. Rottapharm Biotech Srl Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. RaQualia Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 38. RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Major Business
Table 39. RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Total Revenue (USD Million) (2018-2019)
Table 40. RaQualia Pharma Inc SWOT Analysis
Table 41. RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Product and Services
Table 42. RaQualia Pharma Inc Prostaglandin E2 Receptor EP4 Subtype Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global Prostaglandin E2 Receptor EP4 Subtype Sales by Manufacturer (2018-2019) (K Pcs)
Table 44. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global Prostaglandin E2 Receptor EP4 Subtype Sales by Regions (2015-2020) (K Pcs)
Table 46. Global Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Regions (2015-2020)
Table 47. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Regions (2015-2020) (USD Million)
Table 48. North America Prostaglandin E2 Receptor EP4 Subtype Sales by Countries (2015-2020) (K Pcs)
Table 49. North America Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Countries (2015-2020)
Table 50. North America Prostaglandin E2 Receptor EP4 Subtype Revenue by Countries (2015-2020) (USD Million)
Table 51. North America Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Countries (2015-2020)
Table 52. Europe Prostaglandin E2 Receptor EP4 Subtype Sales by Countries (2015-2020) (K Pcs)
Table 53. Europe Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Countries (2015-2020)
Table 54. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Sales by Regions (2015-2020) (K Pcs)
Table 56. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue by Regions (2015-2020) (USD Million)
Table 58. South America Prostaglandin E2 Receptor EP4 Subtype Sales by Countries (2015-2020) (K Pcs)
Table 59. South America Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Countries (2015-2020)
Table 60. South America Prostaglandin E2 Receptor EP4 Subtype Revenue by Countries (2015-2020) (USD Million)
Table 61. South America Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Sales by Countries (2015-2020) (K Pcs)
Table 63. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Countries (2015-2020)
Table 66. Global Prostaglandin E2 Receptor EP4 Subtype Sales by Type (2015-2020) (K Pcs)
Table 67. Global Prostaglandin E2 Receptor EP4 Subtype Sales Share by Type (2015-2020)
Table 68. Global Prostaglandin E2 Receptor EP4 Subtype Revenue by Type (2015-2020) (USD Million)
Table 69. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Share by Type (2015-2020)
Table 70. Global Prostaglandin E2 Receptor EP4 Subtype Sales by Application (2015-2020) (K Pcs)
Table 71. Global Prostaglandin E2 Receptor EP4 Subtype Sales Share by Application (2015-2020)
Table 72. Global Prostaglandin E2 Receptor EP4 Subtype Sales Forecast by Regions (2021-2025) (K Pcs)
Table 73. Global Prostaglandin E2 Receptor EP4 Subtype Market Share Forecast by Regions (2021-2025)
Table 74. Global Prostaglandin E2 Receptor EP4 Subtype Sales Forecast by Type (2021-2025) (K Pcs)
Table 75. Global Prostaglandin E2 Receptor EP4 Subtype Market Share Forecast by Type (2021-2025)
Table 76. Global Prostaglandin E2 Receptor EP4 Subtype Sales Forecast by Application (2021-2025)
Table 77. Global Prostaglandin E2 Receptor EP4 Subtype Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Prostaglandin E2 Receptor EP4 Subtype Picture
Figure 2. Global Sales Market Share of Prostaglandin E2 Receptor EP4 Subtype by Type in 2019
Figure 3. E-7046 Picture
Figure 4. ER-886046 Picture
Figure 5. grapiprant Picture
Figure 6. KAG-308 Picture
Figure 7. ONO-4232 Picture
Figure 8. Others Picture
Figure 9. Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Application in 2018
Figure 10. Breast Cancer Picture
Figure 11. Allergies Picture
Figure 12. Chronic Pain Picture
Figure 13. Acute Pain Picture
Figure 14. Lung Cancer Picture
Figure 15. Others Picture
Figure 16. Global Prostaglandin E2 Receptor EP4 Subtype Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Prostaglandin E2 Receptor EP4 Subtype Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Manufacturer in 2019
Figure 37. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Prostaglandin E2 Receptor EP4 Subtype Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Prostaglandin E2 Receptor EP4 Subtype Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 42. Global Prostaglandin E2 Receptor EP4 Subtype Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Regions (2015-2020)
Figure 44. Global Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Regions in 2018
Figure 45. North America Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
Figure 46. Europe Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
Figure 48. South America Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020)
Figure 50. North America Prostaglandin E2 Receptor EP4 Subtype Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Countries (2015-2020)
Figure 52. North America Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Countries in 2018
Figure 53. North America Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Countries in 2018
Figure 55. United States Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Canada Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Mexico Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Countries in 2019
Figure 61. Germany Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. UK Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. France Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Russia Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Italy Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Regions 2019
Figure 69. China Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Japan Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Korea Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. India Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Southeast Asia Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. South America Prostaglandin E2 Receptor EP4 Subtype Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Countries in 2019
Figure 76. South America Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Countries in 2019
Figure 77. Brazil Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Argentina Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Prostaglandin E2 Receptor EP4 Subtype Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Egypt Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Turkey Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. South Africa Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2015-2020) (K Pcs)
Figure 87. Global Prostaglandin E2 Receptor EP4 Subtype Sales and Growth Rate (2021-2025) (K Pcs)
Figure 88. Global Prostaglandin E2 Receptor EP4 Subtype Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Prostaglandin E2 Receptor EP4 Subtype Market Forecast (2021-2025) (K Pcs)
Figure 90. Europe Sales Prostaglandin E2 Receptor EP4 Subtype Market Forecast (2021-2025) (K Pcs)
Figure 91. Asia-Pacific Sales Prostaglandin E2 Receptor EP4 Subtype Market Forecast (2021-2025) (K Pcs)
Figure 92. South America Sales Prostaglandin E2 Receptor EP4 Subtype Market Forecast (2021-2025) (K Pcs)
Figure 93. Middle East & Africa Sales Prostaglandin E2 Receptor EP4 Subtype Market Forecast (2021-2025) (K Pcs)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel